News

Xylogenics and Lallemand Ethanol Technology Announce An Exclusive Partnership To Develop And Commercialize New Yeasts For Improved Fuel Ethanol Production

Read PDF Version of this article - Click Here

INDIANAPOLIS, IN. and MILWAUKEE, WI. — August 9, 2010 – Xylogenics, Inc., a bioengineering company, and Lallemand Ethanol Technology, a global provider of yeast to the fuel ethanol industry, today announced they have signed an exclusive agreement to develop and commercialize genetically enhanced ethanol producing yeasts for 1st generation fuel ethanol production.

Promising ethanol yeast nears market launch

Read PDF Version of this article - Click Here

IBJ Article by Chris O'Malley - INDIANAPOLIS (June 19, 2010) — A firm that may have developed a breakthrough yeast for ethanol production has landed new investment and high-octane board members.

Two-year-old Xylogenics Inc. also says it plans to license its first bioengineered yeast later this year. This version is intended to boost yields and lower costs of making the automotive fuel ethanol at conventional distilleries that use corn.

Xylogenics Ethanol Bioengineering Firm Announces Three New Members of Board of Directors

Two Xylogenics co-founders earn doctorate degrees.

Read PDF Version of this article - Click Here

INDIANAPOLIS (June 15, 2010) — Indianapolis-based Xylogenics has named three new members to its board of directors. New members include William E. Parry, Joseph J. Prochaska, Jr., and Anthony J. Hubbard. Xylogenics is a bioengineering firm based in Indianapolis that develops genetically modified yeast strains to increase the production efficiency of ethanol from biomass.

Xylogenics Chief Science Officer to Present at Fuel Ethanol Workshop

Mark Goebl, Ph.D., will discuss Xylogenics’ proprietary process to improve the production of cellulosic ethanol through manipulation of yeast.

INDIANAPOLIS (June 11, 2010) — Xylogenics Chief Science Officer Mark Goebl, Ph.D., will speak in a panel session on “Yield Improvements through Fermentation Advances” at the Fuel Ethanol Workshop in St. Louis on June 16, 2010.

Dr. Goebl’s presentation entitled “Cellulosic Ethanol Improved by the Manipulation of Yeast and the Fermentation Environment” will focus on how the Xylogenics technology positively impacts ethanol production by using genetic modifications to improve the conversion of sugar to ethanol. Xylogenics technology will enable ethanol production facilities throughout the U.S. and Canada to boost the fermentation process, increase production efficiency and reduce costs. The Company’s proprietary yeast strains can potentially improve fermentation yields by 30 percent or more.

Dr. Goebl is also Professor of Biochemistry at the School of Medicine at Indiana University.

Looking for more news? Click here to view News Archives

Xylogenics is a bioengineering firm based in Indianapolis that develops genetically modified yeast strains to increase the production efficiency of ethanol from biomass. These proprietary yeast strains can potentially boost fermentation yields by 30 to 50 percent in cellulosic ethanol production facilities. Xylogenics patent pending technology increases the amount of cellulosic material converted to ethanol resulting from its proprietary bioengineered yeast strains optimizing yield efficiencies. For more information, visit www.xylogenicsinc.com.